We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Application form ADV2: register as a person to be notified of an application for adverse possession.
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
This Adverse Weather and Health Plan (AWHP) equity review and impact assessment reviews existing evidence of the risks posed by adverse weather to different populations. It outlines next steps to improve understanding of these risks.
Form NAP: notice to the registrar in respect of an adverse possession application.
Information for manufacturers of medical devices on post-market surveillance, reporting adverse incidents and field safety corrective actions to the MHRA.
Application form ADV1: registration of a person in adverse possession.
The Adverse Weather and Health Plan (AWHP) aims to protect individuals and communities from the health effects of adverse weather and to build community resilience.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).